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Abstract
Sexual health is important to the self worth, emotional well being, and overall quality of life of women in midlife.
However, urinary incontinence, which is prevalent in this population, has a negative impact on sexual function. The
purpose of this article is to review the impact of urinary incontinence on female sexual dysfunction and discuss the
impact of urinary incontinence treatment on sexual function. We carried out a literature review on the effect of
stress urinary incontinence and urgency urinary incontinence on sexual health and physiological response,
including coital incontinence, satisfaction, desire, orgasm, frequency, and partner relationships. We examined the
literature regarding changes in sexual function related to non-surgical and surgical interventions for incontinence.
Overall, though studies are lacking and of poor quality, treatment of incontinence has been shown to improve
sexual function. Both pelvic muscle training and midurethral slings have been shown to improve sexual function in
those with stress urinary incontinence. In urgency urinary incontinence, evidence indicates improvement in sexual
function after treatment with anti-muscarinic medications. Coital incontinence commonly improves with treatment
of the underlying incontinence subtype. Although problems related to sexual health are complex and involve both
psychological and physical factors, it is important to consider treatment of urinary incontinence as part of
management of sexual dysfunction.
Keywords: Sexual function, Sexual dysfunction, Urinary incontinence, Urge urinary incontinence, Stress urinary
incontinence, Coital incontinence, Treatment outcome, Middle aged
Introduction
Urinary incontinence (UI) is a common condition, with
reported prevalence ranging from 28 to 47 % in women
during midlife [1, 2]. The risk of incontinence increases
incrementally from the age of 40 to 60, with prevalence
nearly doubled by age 55 [3]. Common types of incon-
tinence include stress incontinence (urinary leakage with
activity that increase intra-abdominal pressure), urgency
urinary incontinence (leakage related to urgency and irrita-
tive bladder symptoms associated with overactive bladder),
and mixed incontinence (a combination of stress and ur-
gency urinary incontinence). Stress urinary incontinence is
the most common type of urinary incontinence, accounting
for 52 - 65 % of urinary incontinence in women aged 30 to
60 [4]. Treatment of stress UI is primarily surgical, while
urgency urinary incontinence, a common problem that
may affect 20 % of middle-aged women [5], is mainly
treated with non-surgical options. In those with mixed
urinary incontinence, the most bothersome and dominant
incontinence type is treated first. However, coital incontin-
ence, the leakage of urine during sexual intercourse, may
have the most impact on sexual health and commonly
occurs in women with any type of incontinence, with
an overall prevalence from 11 to 60 % in middle-aged
women with UI [6].
UI, even when not directly associated with intercourse,
plays an important role in altering behaviors of human
sexual function. This is concerning, as sexual health is
very important in the overall quality of life and is tied to
a woman’s self worth, emotional well-being, and even
cognitive function [7]. In a recent report, 86 % of women
with urinary incontinence reported that sexual health
was an important issue; however, few women with UI
will discuss problems with sexual health unless directly
asked [8]. Our aim is to review the impact of urinary in-
continence on female sexual dysfunction and discuss the
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impact of urinary incontinence treatment on sexual
health of women in midlife.
Given the rarity of major, high-level evidence with
regards to UI, treatment, and its relationship to sexual
health, we searched for any trials related to these topics,
prioritizing randomized controlled trials and prospective
studies. We conducted a wide and comprehensive litera-
ture search in Pubmed (up to December 2014) on any ar-
ticles examining overall changes in sexual health (overall
subject-described impact). Additionally, we looked for the
impact of urinary incontinence and treatment on aspects
of the sexual physiologic responses (frequency, libido,
desire, arousal, lubrication, orgasm, satisfaction, pain).
No date or language restriction was used. Questionnaires
and questionnaire subdomains used by studies to evaluate
changes in sexual health are briefly described in Table 1.
Review
Urinary incontinence and overall impact on sexual health
Because of the proximity of the bladder and urethra to the
vagina and vulva, UI may have major effects on the sexual
health of affected women. In clinic settings, incontinent
middle-aged women commonly report disruption of sexual
health with a median percentage of 28 % [9]. Complete
abstinence from sex secondary to urinary incontinence
can range from 5.9 to 38 %, a wide range owing to the
diversity of the populations included in these studies
[10–12]. Older women with urinary incontinence re-
port decreased self-rated health and a greater incidence
of depression [5], which may also affect sexual health.
Women with UI show greater dysfunction on validated
sexual function questionnaires compared to those without
incontinence [13], regardless of menopausal status [14].
When examining sexual health in women with stress
UI, older age, postmenopausal state, greater prolapse, and
greater parity have been associated with worse sexual
function scores [15]. The severity and duration of stress
UI may not be associated with the level of sexual function
[16, 17]. In patients with urgency UI, twenty-five percent
of women with urgency UI report negative impacts on
their sex life [18, 19]. Urgency UI is also significantly
associated with lower self-esteem [20], which significantly
influences sexual dysfunction [21].
Impact on the female sexual response
Severe UI has been found to be significantly associated
with decreased libido and vaginal dryness [22], decreased
interest, and decreased satisfaction with sexual intercourse,
including orgasmic dysfunction [9].
In particular, women with stress UI have been noted
to have problems with desire, arousal, and lubrication
[23]. Decreased desire in these women may be related to
unsatisfying partner relationship, worries about coital in-
continence, and unsatisfying somatic health [21]. In spite
of decreased sexual desire, a majority of women with stress
UI (78 %) are able to achieve orgasm [16], and may not
necessarily display decreased sexual activity [24]. Women
with urgency UI similarly also report significant difficulty
with hypoactive sexual desire, and arousal disorder; how-
ever, achieving orgasm is also difficult in this population
[25–27]. In women with urgency UI, this results in de-
creased sexual activity [28] and decreased sexual satis-
faction associated with urgency UI [2].
Table 1 Sexual function questionnaires and subscale domains
Questionnaire or Subscale Name Items Domains/Descriptions
Female Sexual Function Index (FSFI) 19 Desire, Arousal, Satisfaction, Lubrication, Orgasm, Pain
Bristol Female Lower Urinary Tract Symptoms (BFLUTS):
Sex Life Items
4 Urinary related sex life problems (2), Pain, Coital Incontinence
King’s Health Questionnaire (KHQ): Personal Relationship
Domain
3 Relationship with partner, Effect on sex life, Effect of family life
Short form Personal Experiences Questionnaire (SPEQ): 3
Domains
3 Libido, Arousal, Dyspareunia




31: Behavioral/Emotive (15), Physical (10), Partner-related (6) Short form:
Behavioral/Emotive (4), Physical (5), Partner-related (3)
Beck Depression Inventory II: Question 21 1 Loss of interest in sex
Sexual Quality of Life-Female (SQOL-F) 19 Desire, Lubrication, Arousal, Pain, Orgasm, Satisfaction
Arizona Sexual Experience Scale 5 Desire, Arousal, Lubrication, Orgasm, Satisfaction
Nine questions regarding Sexual Functioning (NSF-9) 9 Libido, Frequency, Lubrication, Orgasm, Time to Orgasm, Pain,
Satisfaction
Lemack 8 Presence of pre-operative sexual activity, Frequency, Satisfaction with
intercourse, Satisfaction with surgery, Coital incontinence, Partner pain
Electronic Pelvic Floor Symptoms Assessment Questionnaire
(ePAQ): Urinary domain
4 Impact of urinary symptoms on sex life, Anxiety, Avoidance of sex,
Partner avoidance of sex
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Dyspareunia, pain with intercourse, often accompanies
UI and varies in prevalence from 8 to 42 % amongst
middle-aged women with UI [9]. Studies have reported
significantly greater rates of dyspareunia in women with
UI and other lower urinary tract symptoms compared to
controls [22, 25]. Dyspareunia has been noted more fre-
quently in women with stress UI compared to those with
overactive bladder [15]. However, dyspareunia does com-
monly accompany urgency UI [28, 29].
Impact on partners’ sexual health
UI also affects the sexual function of partners. Male
partners of women with any type of UI report decreased
overall sexual function, satisfaction, frequency of inter-
course, and increased rates of erectile dysfunction as
compared with partners of women without UI [30]. In
spite of these negative effects, 42 % were unaware of the
presence of coital incontinence. Of those who were
aware, the majority (65 %) did not consider the UI to be
the main problem affecting sexual health [21]. Negative
effects on marital relationships have been correlated spe-
cifically with the presence of urgency UI [31].
Coital incontinence and impact on sexual health
Coital incontinence deserves particular focus as it is
often directly associated with sexual dysfunction. Coital
incontinence is prevalent in up to 56 % of middle-aged
women with incontinence [9], and peaks around the age
of 50, with subsequent decrease as women enter their
sixth decade of life [32]. Risk factors for coital incontin-
ence include severity of incontinence [33], obesity [34],
parity [35], and anterior and posterior vaginal wall pro-
lapse [35]. The severity of the coital incontinence may be
associated with the degree of sexual dysfunction [35, 36].
The impact of coital incontinence on sexual function
is multifold. Actual leakage during coitus can affect sexual
satisfaction. However, worry about leakage also contrib-
utes, and is significantly associated with decreased sexual
desire and sexual satisfaction [21]. Embarrassment, guilt
and anxiety about sexual activities are highly prevalent in
this population [37]. Arousal can be also compromised, as
patients with coital incontinence have significantly greater
issues with lubrication [37]. Dyspareunia may be increased
in women with coital incontinence compared to those
without urinary complaints [37]. Avoidance of intercourse
specifically because of coital incontinence is common [37].
Among partners of women with coital incontinence, an
association with increased ejaculation before reaching full
erection was noted [37].
Coital incontinence may occur at any time during
intercourse, but is most commonly noted during penetra-
tion and orgasm [21, 38], although it is also frequently re-
ported during clitoral stimulation and arousal [21]. Coital
incontinence during penetration is commonly associated
with stress UI [35, 39–41], while detrusor spasms have
been implicated in coital incontinence during orgasm
[39, 42]. Coital incontinence resulting from stress UI
during penetration may be due to the alteration of the
urethrovesical angle and elevation of the bladder neck
by the erect penis during moments of increased intra-
abdominal pressure. The mechanism of urinary incon-
tinence during orgasm is unclear. It is postulated that
penile stimulation of the nerve rich area of the bladder
base and trigone may trigger detrusor overactivity in
those with severe overactive bladder [42]. Alternately,
stimulation of the vanilloid receptors in this area, which
are reportedly increased in density in patients with ur-
gency, may trigger detrusor contractions [43]. However,
other studies have found no relationship between timing
of coital incontinence and stress UI, detrusor overactivity,
or mixed urinary incontinence [38, 44]; and that regardless
of timing of coital incontinence, stress UI was the most
frequently diagnosed type of incontinence, while detrusor
overactivity was uncommon [45].
The impact of treatment of urinary incontinence on
sexual health
Treatment of incontinence includes both non-surgical and
surgical modalities. Non-surgical treatment for stress UI
includes pelvic muscle training (strengthening the levator
ani muscles, the main support for the bladder during in-
creased intra-abdominal pressure) [46], anti-incontinence
pessaries, and transvaginal electrical stimulation. However,
the treatment of stress UI is primarily surgical, and in-
cludes midurethral mesh slings, Burch colposuspension,
and periurethral bulking injection (injection of bulking
agents into the urethral wall to improve continence) [47].
Urgency UI is typically treated by non-surgical methods,
including pelvic muscle training and biofeedback, transvagi-
nal electrical stimulation, medication, percutaneous tibial
nerve stimulation (involving stimulation of sacral plexus via
the tibial nerve). Surgical therapies for urgency UI include
botulinum toxin injection of the detrusor muscle and sacral
neuromodulation (implantation of a device that stimulates
the sacral nerve). Treatment of coital incontinence, like
treatment for mixed urinary incontinence, is generally
based on the treatment of the dominant incontinence type.
In the discussion below, we will address the effect of
treatments for stress UI and urge UI on sexual func-
tion, the physiological female sexual response, and coital
incontinence.
Non-surgical treatment of urinary incontinence
Table 2 summarizes the effect of non-surgical treatments
for stress UI and urgency UI on sexual function.
In stress UI, several high level, large trials support the
idea that pelvic floor muscle training can significantly
decrease urinary-related sexual problems [48] as well as
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2. PMFT • PISQ improved
(p = 0.007)
• Greater improvement
3. Combo: 150 3. Combination • Restriction of sex
due to UI improved
(p = 0.008)
• with combo therapy
(p = 0.019) and behavioral
(p = 0.02) vs. pessary alone
• Dyspareunia improved
(p = 0.017)
Transvaginal electrical stimulation (SUI and UUI)





3 months FSFI Significant
improvement in FSFI
and all subscale scores


















effect of OAB on sex
life, interest in sex
Improved
Female: 2508 2. Transdermal
oxybutynin
only








4 mg ER daily
Stable but no
continued
improvement if used 12
additional weeks except
in Physical domain





16 weeks Unknown Sexual dysfunction
decreased
N/A
Chapple et al [56] RCT 1. Placebo: 283 1. Placebo 12 weeks KHQ:
Personal
Patients with OAB, total N/A
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improve sexual physiological response in the areas of de-
sire, arousal, lubrication, orgasm, and satisfaction [49].
These improvements may be correlated to increased pel-
vic muscle strength [49]. Coital incontinence was found
to be improved with muscle training [48, 49]. Pelvic
muscle training, in combination with biofeedback and
occasionally transvaginal electrical stimulation, is also
used to treat urgency UI. The effect on sexual function
in this population has not been extensively studied, and
involves mostly small case series. A small randomized
controlled trial comparing traditional pelvic exercises to
biofeedback-assisted exercises and transvaginal electrical
stimulation found that biofeedback-assisted pelvic floor
muscle training resulted in greatest improvement in
the King’s Health Questionnaire Personal Relationship
domain [50].
Transvaginal electrical stimulation can be used to treat
stress and urgency UI through strengthening of the pelvic
floor muscles. One case series that included 12 women
with stress UI and sexual dysfunction prior to treatment
reported statistically significant improvements in overall
sexual health (as indicated by improvement in Female
Sexual Function Index score) and most subscale do-
mains related to physiological response after 3 months
of transvaginal electrical stimulation therapy [51]. Like-
wise, this modality can be used to treat urgency UI. In
the same case series, which included ten women with
urgency UI, transvaginal electrical stimulation also led
to improved scores in the subjects with urgency UI [51]. A
small randomized controlled trial found that transvaginal
electrical stimulation resulted to less improvement in the
King’s Health Questionnaire Personal Relationship domain
than pelvic muscle training [50].
Anti-incontinence pessaries are commonly used for
stress UI. One randomized controlled trial comparing
anti-incontinence pessaries, pelvic floor muscle training/
continence strategies, or both found no difference in the
rates of incontinence, overall sexual function improvement,
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Female: 76 No significant change
in dyspareunia,
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B-FLUTS Bristol female lower urinary tract symptoms; FSFI Female sexual function index; PISQ-12 Short form pelvic organ prolapse-urinary incontinence sexual
function questionnaire; PFMT Pelvic floor muscle training; RCT Randomized controlled trial; SA Sexual activity; SPEQ: Short form personal experience questionnaire
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or sexual response achieved by pessaries compared to pelvic
muscle training. Pessary users who had improvement
in urinary symptoms (58.8 %) had greater improvement in
overall sexual health (as indicated by higher Pelvic Organ
Prolapse/Incontinence Sexual Questionnaire scores) than
those who did not (2.26 ± 3.24 versus 0.48 ± 3.76, p =
0.0007) [50]. However, pelvic muscle training may be
potentially more effective alone or in combination with
anti-incontinence pessaries than with pessaries alone [50].
Anticholinergic medications are one of the first-line
treatments for urgency UI. Though these medications
are well studied, many large trials do not include specific
assessment of changes in sexual function. Oxybutynin
and tolterodine are two anti-cholinergic medications with
high-quality evidence supporting improvement in sexual
function with use. In the Multicentre Assessment of
Transdermal Therapy in Overactive Bladder with Oxybu-
tynin (MATRIX), which included 2878 subjects, 19.1 % of
women reported improvement in sex life while 11.2 % re-
ported worsening following 6 months of treatment with
oxybutnin [52]. Similar proportions of women reported
improvement in partner relationships and sexual desire
[52]. Treatment with tolterodine was found to improve
overall sexual health (higher sexual function questionnaire
scores) compared with baseline in two studies, with
particular improvement in desire, arousal, orgasm, lubrica-
tion, and satisfaction subscales [53, 54]. Fesoterodine like-
wise was found to improve subjects’ Personal Relationship
scores as compared to controls [55]. Other smaller pro-
spective studies have reported some improvement in
sexual health following treatment with solifenacin [56]
and trospium [57]. Certain trials also found that anti-
muscarinic medication may improve coital incontinence.
In the MATRIX study, oxybutynin was found to decrease
the incidence of coital incontinence from 22.8 to 19.3 %, a
statistically significant change [52]. In a study with toltero-
dine, 59 % of patients with incontinence at orgasm had
improvement in response to tolterodine, though they were
less likely to respond to treatment compared to those
without coital incontinence (41.2 % v 17 %, p = 0.023) [39].
There are currently no studies evaluating the effect of
a newer class of medication, beta-3 agonists, on sexual
health.
Two small, poor quality trials on percutaneous tibial
nerve stimulation found mixed sexual health outcomes.
In two studies that included middle-aged women, one
found no improvement in Female Sexual Function Index
scores [58], while the other noted improvement in the
Nine Questions Regarding Sexual Functioning scores,
particularly in satisfaction, frequency, and orgasm [59].
Overall, there is strong evidence that pelvic muscle
training can significantly improve sexual health in women
with stress and urgency UI respectively. Transvaginal elec-
trical stimulation (for both stress and urgency UI), pelvic
muscle training (urgency UI), and anti-cholinergic medica-
tion (urgency UI) may improve sexual health, but data
is limited by quantity and quality. Literature on anti-in-
continence pessaries (stress UI) and percutaneous tibial
nerve stimulation (urgency UI) show mixed improvement
in sexual health; more trials are needed.
Surgical treatment of urinary incontinence
Surgical treatment of stress and urgency UI differ, but both
seem to result in overall improvement in sexual health.
Table 3 summarizes the effect of surgical treatments of
stress UI on sexual function as reported in prospective
studies. Midurethral slings are the gold standard for treat-
ment of stress UI in middle-aged women, making up the
majority of incontinence procedures performed on women
aged 18 to 64 [47]. The effect of midurethral slings on
sexual health is supported by several large prospective
trials and randomized controlled trials.
There is a trend towards improvement in sexual health
after correction with a midurethral sling. A meta-analysis of
21 studies noted that the pooled chance of improvement of
sexual health following sling placement was 33.9 %, with
improvement ranging from 1.8 to 94 % (0.95, 95 % CI
0.34, 1.56) [44]. One study that included 133 middle-aged
women reported that 40 % of non-sexually active women
reestablished intercourse after surgery [60].
Several studies reported improvement in aspects of
female sexual response. There was an association between
midurethral sling and decreased anxiety [61], resulting in
improvement in sexual spontaneity, arousal, and orgasm
in certain patients [62]. However, when examining other
specific subdomains, most studies found no changes
in sexual desire [63, 64], orgasmic capabilities [63, 64],
intercourse frequency [63, 65], or satisfaction [63, 64]
following sling surgery. Zycynski et al reported im-
provement in dyspareunia rates in a group of 406 subjects
aged 52.9 +/- 11.0 years following sling surgery for stress
UI [66].
Anti-incontinence surgeries can be very effective in
treating coital incontinence. In fact, improvement after
surgery was primarily attributed to decreased urinary-
related sexual complaints such as coital incontinence
[32, 61]. Pooled data on midurethral slings from a meta-
analysis showed a significant reduction in coital incontin-
ence with an OR 0.12 (CI 0.08-0.17) [44]. Post-operatively,
patients also reported decreased fear and embarrassment of
coital incontinence [67]. Women with coital incontinence
and stress UI at baseline were also more likely to display
improvement in frequency and enjoyment of intercourse
as compared to those without coital incontinence (32.5 %
v 6.8 %) [68].
Worsening of sexual function after midurethral sling
placement is less common but possible, approximately
13.1 % in a meta-analysis by Jha et al [44]. This can
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Table 3 Effect of surgical treatments of stress urinary incontinence on sexual function
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Midurethral sling: Retropubic (TVT)
Jha et al [62] Prospective
case series
62 TVT 3 ePAQ N/A • Impact of LUTS on
sex (p < 0.001)
N/A • Partner avoidance
of sex (p = 0.06)
• Improved
(p < 0.001)
• Avoidance of sex
(p < 0.001)
• Anxiety of UI & sex
(p < 0.001)
Ghezzi et al [70] Prospective
case series
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• Fear of CI
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Midurethral sling: Retropubic (TVT) versus Transobterator (TVT-O, TOT) comparative studies
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respectively)
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vaginal narrowing
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(p = 0.026)
• Frequency • Improved
2. TOT:
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Table 3 Effect of surgical treatments of stress urinary incontinence on sexual function (Continued)
2. TOT:
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surgical failure [vs
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• Global sex satisfaction
VAS score (p < 0.001)
CI Coital incontinence; ePAQ Electronic Pelvic Floor Symptoms Assessment Questionnaire; FSFI Female sexual function index; PISQ Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire;
















manifest as new-onset dyspareunia [67], loss of libido
[67], and de novo anorgasmia [64, 69]. The mechan-
ism is not understood, but may be attributed to mesh
complications such as erosion [70], changes in clitoral
blood flow after dissection in the periurethral area,
narrowing of the vaginal opening, or potential injury
to the pudendal nerve branches [70, 71]. Removal or
revision of mesh may improve sexual dysfunction; one
case series showed that use of vaginal estrogen or correc-
tion of erosion after mesh slings were found to have
improvement in all Female Sexual Function Index
scores except orgasm [72].
Burch colposuspension is less commonly used to treat
stress UI given the availability of minimally invasive
techniques. Evidence on the effect of Burch colposuspen-
sion on overall sexual health is poor in quality and contra-
dictory. One retrospective study comparing tension-free
vaginal tape to Burch found no significant difference in
sexual improvement post-operatively, though there was a
non-significant increase in worsening of intercourse after
tension-free vaginal tape [73]. Another small prospective
study found decreased sexual function in both groups, but
to a greater degree in patients who underwent Burch
colposuspension [74].
Periurethal bulking injections are useful for management
of stress UI in women who are poor candidates for general
anesthesia, as these procedures can be performed with local
anesthetics. Data on the effect of bulking agents on sexual
function is limited in number and quality. One small
prospective study on 29 patients (mean age: 53 years
old) treated with polyacrylamide hydrogel injections re-
ported significant improvement in total Pelvic Organ
Prolapse/Incontinence Sexual Questionnaire-12 scores,
and 6 patients reestablished sexual activity post-operatively
[75]. Sexual response (desire, excitement, and orgasm)
likewise improved. Four patients who presented with
coital incontinence prior to injections achieved resolution
of their incontinence [75].
Table 4 shows the effect of surgical treatments of urgency
UI on sexual function. Studies on onabotulinumtoxin A
injection and sexual function have not been conducted,
though an randomized controlled trial by Nitti et al did
note a significant improvement in the King’s Health
Questionnaire Personal Relationships domain score fol-
lowing treatment with Botox in women with urgency
UI [76]. Data on sacral neuromodulation is mixed. Four
low quality studies showed significant improvement in
sexual function questionnaire scores [77–80], while one
did not [81]. Subscale improvements were noted in lubri-
cation, pain, arousal, satisfaction, and orgasm intensity
[77–80]. One case series on sacral neuromodulation in-
dicated decreased coital incontinence in 3 patients, and
cured coital incontinence in 2 patients, as well as de-
creased fear of coital incontinence [79].
Overall, there is high quality data to support improve-
ment of sexual function after treatment with midurethral
slings. Periurethral injection may improve sexual health,
though larger studies are needed. The effect of Burch
Table 4 Effect of surgical treatments of urge urinary incontinence on sexual function
Author Study
Design
N Treatment Instrument Findings
Obotulinumtoxin A injection
Nitti et al [77] RCT 1. Placebo: 243 1. Placebo KHQ (Personal
Relationship Domain)
• Clinically significant improvement in all
KHQ scores, including Personal Relationship
(-13.4 v -1.1, p < 0.001)2. Botox: 249 2. Botox 100 U
follow up: 12 weeks
Sacral neuromodulation
Zahibi et al [78] Prospective
case series
36 SNM follow up:
6 months
FSFI • Significant ↑ FSFI total and all subscale scores
except desire
• Pts with voiding dysfunction only: 157 %
improvement in total FSFI
Signorello et al [79] Prospective
case series
30 SNM follow up:
median 36.3 months
FSFI • Significant improvement in total FSFI and most
domains except orgasm
• 25 % showed >50 % improvement on total FSFI
Gill et al [80] Prospective
case series




• Significant improvement in arousal, satisfaction,
orgasm
• 50 % ↓ CI, restriction of SA due to UI
Pauls et al [81] Prospective
case series
7 SNM FSFI • Significant ↑ frequency, improvement of FSFI total
and desire, lubrication, satisfaction, pain scores
Ingber et al [82] Prospective
case series
27 SNM follow up:
6 months
FSFI • Non-significant improvement in FSFI in OAB
patients (18.6→ 22.4, p = 0.257)
SA Sexual activity, FSFI Female Sexual Function Index; KHQ King’s Health Questionnaire; CI Coital incontinence; RCT Randomized controlled trial;
SNM Sacral neuromodulation
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colposuspension on sexual function is mixed, and more
evidence is required. High quality, large studies examining
the effect of surgical treatments of urgency UI on sexual
function are needed, though sacral neuromodulation
shows promise in a few low quality studies.
Conclusions
Urinary incontinence is a bothersome condition that is
prevalent in middle age women. There is significant data
to support that urinary incontinence is detrimental to
sexual function, especially in women in midlife. While
data on the effect of urinary incontinence treatments on
sexual function is limited by the lack of large trials and
high quality trials, treatment of any incontinence has
been shown to improve sexual function. For stress UI,
non-surgical and surgical treatments - pelvic muscle train-
ing and midurethral slings - have been shown to improve
sexual function. For urgency UI, treatment with pelvic
muscle training and anti-muscarinic medications has the
most evidence of improvement in sexual function. Coital
incontinence generally improves with treatment of the
underlying incontinence subtype. Though problems with
sexual health in middle-aged women with incontinence
are admittedly complex, and involve both psychological
and physical factors, evaluation and treatment of urinary
incontinence is important in the management of this
important issue.
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